Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / Wyoming

Peptide legality · Wyoming · updated 2026-09-21

Are peptides legal in Wyoming?

Gray area

Peptides sit in a legal gray zone in Wyoming, where FDA-approved products are legal by prescription while unapproved research peptides and compounded copies have no lawful human-use pathway.

Legal status overview

Peptides sit in a legal gray zone in Wyoming. The state has no peptide-specific law, so legality depends on federal FDA regulation and the Wyoming State Board of Pharmacy compounding rules under Pharmacy Act Rules Chapter 8, which incorporate federal standards. FDA-approved products such as Wegovy® (semaglutide) and Zepbound® (tirzepatide) are legal only by prescription, while research peptides like BPC-157 and TB-500 have no approved human-use route. Compounding is limited to what federal 503A and 503B rules allow. This is information, not medical or legal advice.

Key points

  • Wyoming has no state-specific peptide law, so legality depends on federal FDA regulation of pharmacy compounding under the 503A and 503B framework. [1]
  • The Wyoming State Board of Pharmacy regulates compounding under Pharmacy Act Rules Chapter 8, which incorporates federal standards rather than creating independent peptide rules. [1]
  • States generally do not set their own substantive baseline for what may lawfully be compounded; that eligibility baseline is fixed federally. [2]
  • Brand-name GLP-1 products such as Ozempic® (semaglutide) and Mounjaro® (tirzepatide) are legal only as prescription FDA-approved drugs. [1]
  • Compounded GLP-1 products are not FDA-approved; not a generic; not evaluated by the FDA, and are restricted to narrow exceptions now that the shortages have ended. [3]
  • BPC-157 was removed from FDA 503A Category 2 in April 2026 and recommended by the advisory committee in July 2026, but the recommendation is not finalized and it remains in regulatory limbo. [4]
  • TB-500 is an unapproved peptide with no Wyoming-specific status; it was among substances discussed for the 503A list in July 2026 but is not yet permitted. [5]
  • Peptides cannot be legally sold for human use in Wyoming without a valid prescription, regardless of research use only labeling. [1]

Compound-by-compound status

BPC-157
Gray area
Unapproved with no USP monograph; removed from FDA 503A Category 2 in April 2026 and recommended for the list in July 2026, but not yet permitted pending final rulemaking. No lawful human-use pathway in Wyoming today.
GLP-1 class, including Wegovy® (semaglutide) and Zepbound® (tirzepatide)
Restricted
Brand-name products are legal by prescription. Compounded versions are not FDA-approved; not a generic; not evaluated by the FDA, and are limited to narrow documented-need exceptions.
TB-500
Gray area
Unapproved research peptide with no lawful human-use prescribing pathway in Wyoming; discussed for the 503A list in July 2026 but not finalized.
Growth hormone / somatropin
Restricted
FDA-approved somatropin is prescription-only for approved indications; no separate Wyoming rule applies and federal law restricts unapproved distribution.

Frequently asked questions

Are peptides legal in Wyoming?

Wyoming has no peptide-specific law. FDA-approved peptide medications are legal with a valid prescription, while unapproved research peptides such as BPC-157 and TB-500 have no lawful human-use pathway. This is information, not advice.

Who regulates peptide compounding in Wyoming?

The Wyoming State Board of Pharmacy regulates compounding under Pharmacy Act Rules Chapter 8, which incorporates the federal 503A and 503B standards, working alongside the FDA.

Can pharmacies compound semaglutide in Wyoming?

Since the FDA declared the shortages resolved, compounding is limited to narrow documented-need exceptions. Compounded semaglutide is not FDA-approved; not a generic; not evaluated by the FDA.

Is BPC-157 legal in Wyoming?

BPC-157 is in a federal gray zone. It was removed from FDA Category 2 in April 2026 and recommended for the compounding list in July 2026, but that recommendation is not finalized and it has no lawful human-use pathway.

Can I buy peptides labeled research use only?

Products labeled research use only are not authorized for human use, and selling them for human consumption has no lawful pathway in Wyoming regardless of the label.

General information based on the sourced research above, not legal advice. For a specific situation in Wyoming, consult a licensed attorney familiar with pharmaceutical law.